IQVIA Holdings, Inc. (IQV)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 17, 2025

$154.10

P/E Ratio

21.00

Market Cap

$26.66B

Description
Add to research
View more

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Metrics
Add to research
View more

Overview

  • HQDurham, NC
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerIQV
  • Price$154.1-3.23%

Trading Information

  • Market cap$26.66B
  • Float99.13%
  • Average Daily Volume (1m)2,526,312
  • Average Daily Volume (3m)2,376,861
  • EPS$7.42

Company

  • Revenue$15.50B
  • Rev growth (1yr)2.43%
  • Net income$249.00M
  • Gross margin27.02%
  • EBITDA margin20.67%
  • EBITDA$792.00M
  • EV$43.91B
  • EV/Revenue2.83
  • P/E21.00
  • P/S1.76
  • P/B4.49
  • Debt/Equity242.71
Documents
Add to research
View more